These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 1542762)

  • 61. [Physiopathology of Raynaud phenomenon: current data].
    Mourad JJ; Priollet P
    Rev Med Interne; 1997; 18(8):611-7. PubMed ID: 9365735
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Raynaud's phenomenon and systemic sclerosis.
    Generini S; Kahaleh B; Matucci-Cerinic M; Pignone A; Lombardi A; Ohtsuka T
    Ann Ital Med Int; 1996; 11(2):125-31. PubMed ID: 8974438
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Raynaud's phenomenon. The French tricolor.
    Klippel JH
    Arch Intern Med; 1991 Dec; 151(12):2389-93. PubMed ID: 1746995
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pathogenesis of Raynaud's phenomenon.
    Herrick AL
    Rheumatology (Oxford); 2005 May; 44(5):587-96. PubMed ID: 15741200
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Rhytidectomy and Raynaud's phenomenon: about two cases].
    Nicolas J; Labbé D
    Ann Chir Plast Esthet; 2004 Dec; 49(6):564-8. PubMed ID: 15582213
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Treatment of Raynaud's phenomenon.
    García-Carrasco M; Jiménez-Hernández M; Escárcega RO; Mendoza-Pinto C; Pardo-Santos R; Levy R; Maldonado CG; Chávez GP; Cervera R
    Autoimmun Rev; 2008 Oct; 8(1):62-8. PubMed ID: 18692160
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pathophysiology of vibration-induced white fingers--current opinion: a review.
    Liapina M; Tzvetkov D; Vodenitcharov E
    Cent Eur J Public Health; 2002 Jun; 10(1-2):16-20. PubMed ID: 12096677
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pathophysiology of white fingers in workers using hand-held vibrating tools.
    Gemne G
    Nagoya J Med Sci; 1994 May; 57 Suppl():87-97. PubMed ID: 7708114
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Limitations of cold tests in Raynaud's disease].
    Vayssairat M; Baudot N; Blaison N; Evenou P; Gilard M; Mathieu JF
    J Mal Vasc; 1990; 15(1):82-5. PubMed ID: 2179450
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Serotonin and Raynaud's phenomenon.
    Seibold JR
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S95-8. PubMed ID: 2412070
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [The controversy of primary Raynaud syndrome].
    Gasser P
    Schweiz Rundsch Med Prax; 1992 Feb; 81(9):243-5. PubMed ID: 1542762
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [What is the role of the sympathetic nervous system in digital vasospasms?].
    Gasser P
    Praxis (Bern 1994); 1996 Oct; 85(42):1320-3. PubMed ID: 8966429
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Raynaud's phenomenon: pathogenesis and management.
    Bakst R; Merola JF; Franks AG; Sanchez M
    J Am Acad Dermatol; 2008 Oct; 59(4):633-53. PubMed ID: 18656283
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Calcium antagonists and Raynaud's phenomenon].
    Hachulla E; Devulder B
    Therapie; 1993; 48 Spec No():707-11. PubMed ID: 8091357
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The role of the sympathetic nervous system in the pathophysiology and therapy of Raynaud's phenomenon.
    Wollersheim H; Cleophas T; Thien T
    Vasa Suppl; 1987; 18():54-63. PubMed ID: 3299816
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.